Lilly and Precision BioSciences Announce Genome Editing Research Collaboration and License Agreement

Refer to: | Mark Taylor;?mark.taylor@lilly.com; (317) 276-5795 (Lilly?Media) |
Kevin Hern;?hern_kevin_r@lilly.com; (317) 277-1838 (Lilly Investors) | |
Maurissa Messier;?Maurissa.Messier@precisionbiosciences.com; (Precision Media) | |
Alex Kelly;?Alex.Kelly@precisionbiosciences.com; (Precision Investors) |